CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF-1

Tian, X.; Nguyen, M.; Foote, H. P.; Caster, J. M.; Roche, K. C.; Peters, C. G.; Wu, P.; Jayaraman, L.; Garmey, E. G.; Tepper, J. E.; Eliasof, S.; Wang, A. Z.

期刊名称Cancer Research
作者Tian, X.; Nguyen, M.; Foote, H. P.; Caster, J. M.; Roche, K. C.; Peters, C. G.; Wu, P.; Jayaraman, L.; Garmey, E. G.; Tepper, J. E.; Eliasof, S.; Wang, A. Z.
印刷ISSN0008-5472
电子ISSN1538-7445
文件大小2620.58KB
发表时间2016-10-26
DOI10.1158/0008-5472.CAN-15-2951

发现好书期刊，享受阅读乐趣

CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF-1